Clinical Trial Update: DESTINY TRIAL (Inspiron x Biomatrix) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for DESTINY TRIAL (Inspiron x Biomatrix) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biomatrix
• Inspiron

Snippet

Sponsor: Scitech Produtos Medicos SA | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED